XML 54 R39.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock Based Compensation (Tables)
12 Months Ended
Dec. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award
Roll Forward Schedule of Long Term Incentive Plan by Shares and Weighted Average Exercise Prices

 
Long Term Incentive Plan
Roll Forward of Shares Outstanding:
 
Outstanding at January 1, 2017
366,329

Granted
55,621

Exercised
(58,804
)
Forfeited
(16,991
)
Outstanding at December 31, 2017
346,155

Exercisable at Period-End
225,694

Vested and Expected to Vest
120,461

 
 
Roll Forward of Shares Outstanding - Weighted Average Exercise Price:
 
Outstanding at January 1, 2017
$
21.86

Granted
36.12

Exercised
20.25

Forfeited
28.27

Outstanding at December 31, 2017
24.12

Exercisable at Period-End
21.61

Vested and Expected to Vest
28.80

 
 
Weighted Average Remaining Contractual Life (in years):
 
Outstanding at December 31, 2017
5.11

Exercisable at December 31, 2017
3.54

Vested and Expected to Vest
8.05

 
 
Aggregate Intrinsic Value:
 
Outstanding at December 31, 2017
$
3,403

Exercisable at December 31, 2017
2,785

Vested and Expected to Vest
618

 
 
Shares Available for Grant at Period-End
340,178

Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range
Schedule of Shares Authorized Under the Long Term Incentive Plan by Exercise Price Range
 
Exercise Price Ranges
 
$18.00
$20.17 to $21.56
$22.14 to $22.65
$23.89 to $24.37
$36.12
Total
Outstanding at December 31, 2017
 
 
 
 
 
 
Number of Shares Outstanding
27,999

85,068

94,111

89,536

49,441

346,155

Weighted-Average Remaining Contractual Life (in years)
1.06

2.58

4.49

7.27

9.07

5.11

Weighted-Average Exercise Price
$
18.00

$
20.98

$
22.43

$
24.15

$
36.12

$
24.12

 
 
 
 
 
 
 
Exercisable at December 31, 2017
 
 
 
 
 
 
Number of Shares Outstanding
27,999

85,068

79,797

31,800

1,030

225,694

Weighted-Average Remaining Contractual Life (in years)
1.06

2.58

4.20

6.49

9.07

3.54

Weighted-Average Exercise Price
$
18.00

$
20.98

$
22.39

$
24.08

$
36.12

$
21.61

Other Stock Based Compensation Disclosure Table
Schedule of Other Long Term Incentive Plan Information
 
 
2017
 
2016
 
2015
Shares Granted
 
55,621

 
58,350

 
58,975

Weighted Average Grant Date Information:
 
 
 
 
 
 
Fair Value of Options Granted
 
$
6.25

 
$
5.44

 
$
5.34

Fair Value Assumptions:
 
 
 
 
 
 
Dividend Yield
 
2.72
%
 
3.88
%
 
3.90
%
Expected Volatility
 
21.40
%
 
32.95
%
 
33.55
%
Risk Free Interest Rate
 
2.25
%
 
1.80
%
 
1.57
%
Expected Lives (in years)
 
6.88

 
7.56

 
7.66

 
 
 
 
 
 
 
Amount Expensed During the Year
 
$
351

 
$
287

 
$
308

Compensation Costs for Non-vested Awards Not Yet Recognized
 
528

 
521

 
500

Weighted Average Expected Vesting Period, In Years
 
2.59

 
2.71

 
2.12

Proceeds From Stock Options Exercised
 
$
1,190

 
$
2,404

 
$
918

Tax Benefits Related to Stock Options Exercised
 
168

 
188

 
59

Intrinsic Value of Stock Options Exercised
 
825

 
1,010

 
250

Schedule of Employee Stock Ownership Plan (ESOP) Disclosures
Schedule of ESOP Compensation Expense
 
 
2017
 
2016
 
2015
ESOP Compensation Expense
 
$
1,400

 
$
1,200

 
$
900


Shares pledged as collateral are reported as unallocated ESOP shares in stockholders equity.  As shares are released from collateral, Arrow reports compensation expense equal to the current average market price of the shares, and the shares become outstanding for earnings per share computations.  The ESOP shares as of December 31, 2017 were as follows:

Schedule of Shares in ESOP Plan
ESOP Plan Shares:
2017
Allocated Shares
759,081

Shares Released for Allocation During 2017
10,407

Unallocated Shares
9,643

Total ESOP Shares
779,131

 
 
Market Value of Unallocated Shares
$
327